tirzepatide 2023 F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Tirzepatide vs. Semaglutide for Weight

"Our nomination provides numerous examples of these risks, including unknown impurities, peptide-related impurities, incorrect strengths, and even instances where no semaglutide was present in the product at all," Novo Nordisk spokesperson Jamie Bennet wrote in an email to NPR

And it explains why some patients who respond poorly to liraglutide see better results when switching to semaglutide, despite both drugs targeting the exact same receptor

In addition, patients with severe liver, kidney problem, uncontrolled diabetes and thyroid problem would be contraindicated as well

Most recently, in April, CMS rejected Humanas internal administrative appeal to change its rating

(PubMed) Brace LD

(2.1) Start at 0.25 mg once weekly